Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis (original) (raw)
Microglial Phenotypes and Functions in Multiple Sclerosis
Oleg Butovsky
Cold Spring Harbor Perspectives in Medicine, 2018
View PDFchevron_right
Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis
Monica Carson
2002
View PDFchevron_right
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Nicole Kerlero De Rosbo, Christian Cordano
Immunology, 2014
View PDFchevron_right
Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed
Joost Smolders
Glia, 2013
View PDFchevron_right
Diverse Targets for Intervention during Inflammatory and Neurodegenerative Phases of Multiple Sclerosis
Lawrence Steinman, Scott Zamvil
Neuron, 2003
View PDFchevron_right
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Simon Hametner
Brain
View PDFchevron_right
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing–remitting experimental autoimmune encephalomyelitis
Morten Meyer
Brain, 2007
View PDFchevron_right
Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment
Anne-marie Van Dam
Acta Neuropathologica Communications
View PDFchevron_right
Glial Cells and Products of Activated Inflammatory Cells: Implications for Pathogenesis and Treatment of Multiple Sclerosis
Robert Lisak
1988
View PDFchevron_right
Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia
Lesley Probert
JCI Insight, 2017
View PDFchevron_right
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS – No
Robert Weissert
Multiple Sclerosis Journal, 2018
View PDFchevron_right
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies
Amedeo Amedei
International journal of molecular sciences, 2012
View PDFchevron_right
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection
Nicole Schaeren-wiemers
Brain, 2007
View PDFchevron_right
Multiple sclerosis: a battle between destruction and repair
Claude Bernard
Journal of Neurochemistry, 2007
View PDFchevron_right
The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations
Nafiseh Esmaeil
Frontiers in Immunology, 2021
View PDFchevron_right
Elevated Activity and Microglial Expression of Myeloperoxidase in Demyelinated Cerebral Cortex in Multiple Sclerosis
Seth Love
Brain Pathology, 2008
View PDFchevron_right
Reducing the phagocytic ability of monocytes in patients with multiple sclerosis
Nemanja Zdravkovic
Serbian Journal of Experimental and Clinical Research, 2008
View PDFchevron_right
Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis
Jeffrey Bennett
Clinical Neuropharmacology, 2009
View PDFchevron_right
Inflammasome-mediated activation of microglia differs importantly from that of hematopoietic macrophages
Ivanela Kondova
Journal of Neuroimmunology, 2014
View PDFchevron_right
Microglial Recruitment, Activation, and Proliferation in Response to Primary Demyelination
Trevor Owens
The American Journal of Pathology, 2007
View PDFchevron_right
Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout mice
Samantha Soldan
Journal of Neuroimmunology, 2003
View PDFchevron_right
Immunopathophysiologic basis of multiple sclerosis and implications for therapy-a narrative review
Jan Redfern
Pharmacy & Pharmacology International Journal, 2021
View PDFchevron_right
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
Kathie Mihindukulasuriya
Acta Neuropathologica
View PDFchevron_right
In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressed
Nieske Brouwer
Glia, 2014
View PDFchevron_right
An updated assessment of microglia depletion: current concepts and future directions
Robert Harris
Molecular brain, 2017
View PDFchevron_right
Mechanisms of tissue injury in multiple sclerosis: opportunities for neuroprotective therapy
Dr. Uma Ladiwala
Advances in Research on Neurodegeneration, 2000
View PDFchevron_right
Differential roles of microglia and monocytes in the inflamed central nervous system
Oleg Butovsky
Journal of Experimental Medicine, 2014
View PDFchevron_right
The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
Nikolaos Grigoriadis
Healthcare
View PDFchevron_right
IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity
Reiner Schneider
Acta neuropathologica communications, 2015
View PDFchevron_right
Myeloid cells — targets of medication in multiple sclerosis
Manoj Mishra
View PDFchevron_right
{"__content__"=>"Significance andDetection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.", "i"=>{"__content__"=>"In Vivo"}}
thanh nguyen
Frontiers in immunology, 2018
View PDFchevron_right
The essential role of t cells in multiple sclerosis: A reappraisal
Bruno Gran
Biomedical Journal, 2014
View PDFchevron_right
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice
Muhammad Sohel Mia
Glia, 2014
View PDFchevron_right
Mechanisms of neurobehavioral abnormalities in multiple sclerosis: Contributions from neural and immune components
diego jacobo
Clinical Neurophysiology Practice, 2019
View PDFchevron_right